Financial Advocates Investment Management Astrazeneca PLC Transaction History

Financial Advocates Investment Management

$1.78 Billion
Q3 2024

A detailed history of Financial Advocates Investment Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Financial Advocates Investment Management holds 14,960 shares of AZN stock, worth $996,784. This represents 0.07% of its overall portfolio holdings.

Number of Shares

14,960

Previous 14,762 1.34%

Holding current value

$996,784

Previous $1.15 Million 1.22%

% of portfolio

0.07%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$76.67 - $87.62 $15,180 - $17,348	198 Added 1.34%	14,960 $1.17 Million
Q2 2024 Jul 26, 2024	BUY	$66.81 - $80.83 $145,512 - $176,047	2,178 Added 17.31%	14,762 $1.15 Million
Q1 2024 May 01, 2024	BUY	$61.03 - $69.57 $854 - $973	14 Added 0.11%	12,584 $852,000
Q4 2023 Feb 08, 2024	BUY	$61.89 - $69.28 $90,978 - $101,841	1,470 Added 13.24%	12,570 $846,000
Q3 2023 Oct 27, 2023	BUY	$64.85 - $71.7 $115,757 - $127,984	1,785 Added 19.16%	11,100 $751,000
Q2 2023 Aug 07, 2023	SELL	$69.91 - $75.81 $978 - $1,061	-14 Reduced 0.15%	9,315 $666,000
Q1 2023 May 11, 2023	SELL	$63.15 - $71.6 $4,546 - $5,155	-72 Reduced 0.77%	9,329 $647,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $161,112 - $209,347	2,972 Added 46.23%	9,401 $637,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $98,670 - $252,630	1,861 Added 40.74%	6,429 $536,000
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $4,266 - $5,122	72 Added 1.6%	4,568 $302,000
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $6,184 - $7,450	111 Added 2.53%	4,496 $299,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $9,129 - $10,787	-169 Reduced 3.71%	4,385 $265,000
Q3 2021 Nov 04, 2021	BUY	$55.56 - $60.79 $61,727 - $67,537	1,111 Added 32.27%	4,554 $273,000
Q2 2021 Aug 03, 2021	SELL	$48.42 - $60.18 $21,159 - $26,298	-437 Reduced 11.26%	3,443 $206,000
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $2.64 Million - $3.39 Million	-61,260 Reduced 94.04%	3,880 $205,000
Q4 2018 Mar 04, 2019	BUY	$36.86 - $41.49 $2.37 Million - $2.66 Million	64,175 Added 6650.26%	65,140 $3.88 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $27,497 - $30,951	-746 Reduced 43.6%	965 $36,000
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $59,474 - $67,960	1,711 New	1,711 $0

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.

Account

Financial Advocates Investment Management Astrazeneca PLC Transaction History